Inventor · disambiguated record
Kiyean Nam
Also filed as: NAM KIYEAN
7 granted patents·7 pending applications·28 citations·filing 2012–2023
74Inventor score
Top patents by PatentIndex Score
14 records- 0187US9029389B2Anti-inflammation compoundsNO ZAESUNG·Filed 2012·Granted May 12, 2015·27 cites·13 claims
- 0270US11858937B2Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitorsQURIENT CO LTD·Filed 2019·Granted Jan 2, 2024·1 cites·47 claims
- 0360US2025205242A1Cdk7 inhibitors for antiviral treatmentQURIENT CO LTD·Filed 2023·Application pending·0 cites
- 0454US2024415819A1Macrocyclic compounds as proteasome subunit beta type-5 inhibitorsLEAD DISCOVERY CENTER GMBH·Filed 2022·Application pending·0 cites
- 0554US2024343732A1Compounds for degradation of cyclin-dependent kinase 7(cdk7)QURIENT CO LTD·Filed 2022·Application pending·0 cites
- 0653US12410165B2Different forms of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamideQURIENT CO LTD·Filed 2019·Granted Sep 9, 2025·0 cites·16 claims
- 0753US2025263413A1Compounds having cyclin-dependent kinase(cdk)-inhibitory functionQURIENT CO LTD·Filed 2021·Application pending·0 cites
- 0851US2025188058A1New forms of n-(5-((6,7-dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-1-propyl-4-(2,2,2-trifluoroethoxy)-1h-pyrazole-3-carboxamide hydrochlorideQURIENT CO LTD·Filed 2022·Application pending·0 cites
- 0945US2023055208A1A pharmaceutical oral dosage form of q203QURIENT CO LTD·Filed 2020·Application pending·0 cites
- 1040US12162858B2Quinoline derivatives as inhibitors of AXL/MER RTK and CSF1RQURIENT CO LTD·Filed 2019·Granted Dec 10, 2024·0 cites·23 claims
- 1139US11945822B2Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinaseQURIENT CO LTD·Filed 2019·Granted Apr 2, 2024·0 cites·20 claims
- 1238US2016185774A1Anti-Infective CompoundsPASTEUR INSTITUT KOREA·Filed 2014·Application pending·0 cites
- 1329US10934274B2Quinoline derivatives as TAM RTK inhibitorsQURIENT CO LTD·Filed 2016·Granted Mar 2, 2021·0 cites·16 claims
- 1426US11447486B22-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitorsPASTEUR INSTITUT KOREA·Filed 2015·Granted Sep 20, 2022·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Kiyean Nam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →